ABSTRACT We have constructed bovine papilloma virus recombinants carrying a. hybrid gene in which human growth hormone structural sequences are fused to the promoter. and presumptive control region -of the mouse metallothionein-I gene. Mouse cells transformed with the recombinants synthesize metallothionein-growth hormone hybridmRNA with the same 5' end as metallothionein mRNA. Hybrid MnRNA is inducible by cadmium but not by. dexamethasone, whereas the chromosomal metallothionein genes in -the same cells are inducible by both agents. This indicates that heavy metals and glucocorticoids regulate the mouse metallothionein-I gene by independent mechanisms. Furthermore, because the transformed cells produce large quantities of human growth hormone polypeptide, it appears that bovine papilloma virus-metallothionein vectors may be useful for obtaining the efficient and regulatable expression of other eukaryotic gene products. We have constructed recombinants that allow the insertion of new structural sequences under the control of the metallothionein promoter.
metal-binding proteins. They have been found in all eukaryotic species examined and in many different organs and cell types (reviewed in ref. 1) . MT gene expression is inducible both by heavy metals, such as cadmium (2) (3) (4) , and by glucocorticoids, such as dexamethasone (5) (6) (7) (8) (9) . Heavy metal regulation serves as an important mechanism in cadmium and mercury detoxification and may also play a role in zinc and copper homeostasis. Induction by glucocorticoids is, in most cases, less -efficient than by heavy metals, and its physiological role is still uncertain. Nevertheless, it appears that the MT system might provide a useful model~for understanding how a single gene can be regulated by two very different classes of inducers.
Our understanding ofMT regulation will, in the end, depend upon the ability to reconstruct the system from purified components. Recently it was shown that a cloned MT-I gene retains its inducibility by cadmium when introduced into cells by microinjection (10, 11) , cotransformation (12) , or transfection with simian virus 40 (SV40) recombinants (13) . In an attempt to extend these observations, we have constructed a 'MT-human growth hormone (hGH) hybrid gene, cloned it in a bovine papilloma virus (BPV) vector (14) , and introduced the recombinant molecules into cultured mouse cells. We show that the hybrid gene is regulated by cadmium, but not by dexamethasone, whereas the chromosomal genes in the same cells are induced by both agents. This clearly establishes that glucocorticoid regulation does not occur via an increase in the pool of available intracellular metal, but rather by some independent mechanism. We have also found that hGH polypeptide synthesis is inducible by cadmium in the transformed cells and that very high levels of protein are accumulated. Some possible uses of BPV-MT recombinants as eukaryotic expression vectors are discussed.
MATERIALS AND METHODS
The construction ofthe BPVMG (BPV-MT-hGH) recombinants involved four steps (see Fig. 1 ): First, the genomic hGH sequences (15) between the Pvu II site in exon 2 and the Bgl II site in exon 5 were replaced with the corresponding fragment of an hGH cDNA clone (16) . The resulting hGH "mini-gene" directs hGH synthesis in monkey cells infected with an SV40 recombinant (unpublished results). The mini-gene was excised from its pBR322-SV40 vector (17, 18) with BamHI, which cuts at the 5' end of exon 1 and in' plasmid DNA downstream from the gene. Second, this fragment was subcloned in the Bgl II site in the 5' untranslated region of the mouse MT-I gene in pJYMMT(E) (13) . Third, the hybrid gene was recovered by HindIII digestion and inserted into pBPV69TD partially digested with HindIII. -Plasmid pBPV69TD consists of the 69% BamHI/HindIII transforming fragment of BPV-I cloned in pBR322 (14, 19) . Fourth, the plasmid sequenceswere removed by BamHI cleavage and the BPV-MT-hGH recombinants were circularized by treatment -with DNA ligase. To construct pBPVMT1 and pBPVMT5, pJYMMT(E) was digested with HindIII and the 3,300-base-pair (bp) fragment containing the mouse MT-I gene and 5' flanking sequences was cloned in pBPV69TD partially digested with HindIII. Recombinant DNA experiments were conducted in accordance with the National Institutes of Health guidelines.
Mouse C127 cells (20) were transformed with recombinant 'DNA by the' calcium precipitation method (21) as described by Sarver et al. (14) . Individual foci were picked,' put.into 24 (19) . and a BPV-rat insulin recombinant (14) , respectively. The following methods -have been described: preparation of high molecular weight cell DNA (22) ; gel transfer hybridization (23) to a BPV DNA probe labeled by nick-translation (24) ; isolation of total cell poly(A)+ RNA by extraction with hot phenol (25) and oligo(dT)-cellulose chromatography (26) ; nuclease S1 mapping. (13, 27, 28) of RNA by using 5'-end-labeled probes (29) (14) . The two recombinant viruses, BPVMG6
and BPVMG7, were generated by excision of the plasmid sequences followed by recirculariiation (Fig. 1B) . The transcriptional orientations of the hybrid gene and BPV are in tandem in BPVMG7 and opposed in BPVMG6 (30, 31) .. These molecules were transfected into mouse C127 cells and transformants were picked on the basis of their altered morphology. All ofthe first 25 clones isolated produced and secreted hGH as determined by radioimmunoassays of the media. Clones were named CBMG6-n (carrying the BPVMG6 recombinant) and CBMG7-n (carrying the BPVM'G7 recombinant). To establish the status of the recombinant molecules in the transformed lines, we extracted their total DNA and analyzed it by gel transfer hybridization to a BPV probe. sodium dodecyl sulfate gels (17) ; and analysis ofintracellular MT by electrophoresis of carboxymethylated cell extracts through nondenaturing 20% acrylamide gels (13 (14, 32) , that the recombinant molecules are maintained primarily or exclusively as episomes. By comparison with a plasmid DNA standard we estimate that the transformants contain between 10 and 100 copies of the recombinant molecules per cell. The presence of faint bands in some of the digests may reflect minor rearrangements in the DNA or the presence of more than one cell type. Two of the clones (6-2 and 6-3) gave different restriction patterns indicative of gross rearrangements. One ofthese lines (6-3) was unstable and stopped producing hGH after 5 months of culture. In contrast, all ofthe 10 clones with the expected DNA structure continued to produce hGH after 1 year ofcontinuous passage. Analysis of the low molecular weight Hirt supernatant DNA (33) from three clones that had been grown for 10 months showed no alterations in DNA structure and confirmed the presence of supercoiled episomal molecules (results not shown).
We have also constructed pBR322-BPV-MT recombinants that can be used to bring other structural sequences under control of the MT-I promoter (Fig. 1C) . These recombinants, designated pBPVMT1 and pBPVMT5, can be partially digested with Bgl II for insertion into the 5' untranslated region of the MT-I gene. The plasmid sequences can subsequently be removed by HindIII cleavage.
Regulation of Hybrid mRNA. We expected the MT-hGH -hybrid gene to encode a hybrid mRNA initiated at the MT-I gene promoter. To detect and map the 5' end of these transcripts we performed nuclease S1 protection experiments with a probe 5'-end-labeled at the Ava II site in the hGH portion ofthe first exon ofthe hybrid gene (Fig. 1A) . Fig. 3A shows that RNA from the transformed mouse cells protected a predominant fragment of 100 bases, corresponding to the distance between the end label and the 5' end of the MT-I gene. Several larger bands were also protected in variable quantities, probably due to partial nuclease Si digestion or secondary structure in the single-stranded DNA extending from the DNARNA hybrid. The specificity of this assay is shown by the fact that RNA from untransformed C127 cells gave no protected bands. The regulation of hybrid mRNA synthesis was studied by nuclease SI mapping of the RNA from cells grown in media containing cadmium, dexamethasone, or no inducer. The RNA samples were hybridized to the hybrid gene-specific probe and the intensities ofthe protected bands were quantitated by densitometry of the autoradiograms. Typical results for four different clones are shown in Fig. 3 . We consistently observed increased levels of hybrid mRNA in the cadmium-treated cells. Induction ratios varied between 2-fold (clone 6-3) and 7-fold (clone 7-4). In contrast, induction by dexamethasone was not consistently observed. In the experiment shown in Fig. 3 , in which we used RNA from approximately equal numbers ofcells, the amount of hybrid RNA in the dexamethasone-induced cells is less than in the uninduced cells for clones 6-3 and 6-7. Dexaamethasone inhibits total RNA and protein synthesis by 10-20% in our clones. If we normalize the nuclease S1 mapping results for equal amounts of RNA we find no significant difference at the levels of hybrid mRNA after dexamethasone induction. In some experiments we found a slight induction (1.1-to 2-fold) by dexamethasone, but this result was not reproducible.
As a control for this experiment, the same RNA samples were hybridized to a MT-I gene probe (Fig. 1A) that will detect the RNAs encoded by the endogenous mouse MT-I gene as well as the cloned hybrid gene. As shown in Fig. 3B , regulation by both cadmium and dexamethasone was consistently observed with this probe. This demonstrates that the transformed cells have retained their ability to respond to both heavy metal and glucocorticoid induction.
hGH Production. hGH is synthesized in the pituitary as a prehormone containing a hydrophobic amino-terminal se- quence that is removed during secretion. We have shown-previously that cultured monkey kidney cells infected with SV40-hGH recombinants are capable of both processing and secreting hGH (17) . To determine ifthis was also true for the BPVMG transformants, cells were labeledwith [35S]cysteine and the secreted proteins in the media were analyzed by gel electrophoresis. Fig. 4A shows a typical analysis of clone 7-4. A protein migrating with authentic hGH was observed in the medium from the BPVMG-transformed cells but not from control ID13 cells. Furthermore, when cells were induced for 8 hr with cadmium or dexamethasone, the amount of this protein was increased 2-fold by cadmium but was unaffected by dexamethasone (Fig. 4B) ; We also observed variable quantities ofa higher molecular weight band.in the transformed cells. Although this protein has not been characterized, it is interesting to note that it migrates approximately at the position expected for pre-hGH. Parallel analysis of the labeled intracellular proteins from the same cells showed that MT synthesis was induced by both cadmium and d-examethasone (Fig. 4C ). This confirms that the endogenous MT genes in the transformed-cells have retained their responsiveness to both heavy metals and-glucocorticoids. From scans of such gels we estimate that the transformed cells produce 20-to 60-fold more hGH than MT. (Note that MT contains 20 cysteine residues, whereas hGH contains only 4.) The amount of hGH secreted by the transformed mouse cells was quantitated by radioimmunoassay. Fig. 5 shows results for nine clones 1 month after the initial transfection-of C127 cells.
Basal levels ranged between 0.2 and 2.5 tkg/ml, and these levels were increased 1.3-to 2.5-fold by treatment with cadmium but not by dexamethasone. The hGH production levels remained constant or actually increased as the cells were~contin-uously passaged for 10 months (except for the unstable clone 6-3). Measurements of cell number-and medium hGH for cells that had been in culture for 10 months showed basal levels of hGH production of 2-6 x 108 molecules per cell per day in four different clones.
DISCUSSION
We have studied the expression of a MT-hGH hybrid gene cloned in BPV. Three reasons prompted us to use BPV as the vector for these experiments. First, BPV can transform mouse cells, so it was possible to return the MT-I sequences into cells of the species from which they were cloned. Second, BPV replicates at relatively low levels (10-100 copies per cell) compared to the SV40 vectors (105L106 copies per cell) used previously in our laboratory (13) . Third, because BPV replicates as an episome, all of the recombinant DNA molecules in a given clone should be in the same chromatin environment; this is in contrast to DNA cotransformation experiments (12) , in which the recombinant DNA integrates into the chromosome in an apparently random fashion. Finally, because the transformed lines are stable, it is possible to carry out the experiments over a long period of time and to collect large quantities of the secreted hGH. The expression of the hybrid gene was inducible by cadmium. This demonstrates that BPV can be used to study reg- (12) or microinjection into embryos (10) . This suggests that our result is not due to an artifact ofthe BPV vector system. Glucocorticoid inducibility is also lost in cadmium-resistant cells containing amplified MT-I genes (34) . However, sequence analysis has shown that our MT-I gene, which was cloned from cadmium-resistant L cells (13) , is identical to the gene cloned from cadmium-sensitive myeloma cells (35) for at least 300 bp of 5' flanking sequences and all of the 5' untranslated sequences (unpublished results). One possible explanation of our results is that the glucocorticoid regulatory sequences of the mouse MT-I gene lie outside of this region. Another possibility is that glucocorticoid regulation of the mouse MT-I gene requires a specific chromatin environment or other epigenetic information that is lost during the cloning procedures. The one clear conclusion that can be drawn from our-data is that glucocorticoids and heavy metals regulate the mouse MT-I gene by independent mechanisms. Glucocorticoids cannot be simply increasing the concentration ofavailable intracellular metal because this would have resulted in an induction of the hybrid gene.
Mouse cells transformed with the BPVMG recombinants secrete large quantities of hGH. Basal levels, measured on cells passaged for more than 10 months, were 2-6 X 108 molecules per cell per day. This is more than 10 times the amount ofhGH produced in monkey kidney cells lytically infected with SV40 recombinants carrying the intact hGH gene (17) . The high production levels and stability of the transformed clones suggest that BPVMT vectors might be useful for producing other eukaryotic gene products. Overproduction of MT makes the cells resistant to cadmium and can be utilized as a simple dominant selection (unpublished data). Furthermore, the ability to regulate the expression of inserted structural sequences by cadmium should make it possible to overproduce toxic products and to study the physiological effects ofproteins for which the genes are available but the functions are unknown.
